Dr. Liu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1425 S Main St
Walnut Creek, CA 94596Phone+1 925-295-4000
Education & Training
- Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2000 - 2003
- Abington Memorial HospitalResidency, Internal Medicine, 1997 - 2000
- Beijing Medical UniversityClass of 1989
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- PA State Medical License Current
- CA State Medical License 2002 - 2026
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 1 citationsThe single cell immunogenomic landscape after neoadjuvant immunotherapy combined chemotherapy in esophageal squamous cell carcinoma.Zheyi Wang, Yue Zhao, Yang Wo, Yizhou Peng, Weilei Hu
Cancer Letters. 2024-07-01 - 3 citationsIntegrative tumour mutation burden with CD39 and PD-L1 for the prediction of response to PD-L1 blockade and adjuvant chemotherapy in muscle-invasive bladder cancer pat...Chunnan Liu, Zhaopei Liu, Kaifeng Jin, Han Zeng, Fei Shao
British Journal of Cancer. 2022-11-01 - 2 citationsImmune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer.Yanze Yu, Han Zeng, Kaifeng Jin, Runze You, Zhaopei Liu
Cancer Immunology, Immunotherapy. 2022-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: